Atlas Venture Associates Ix, LLC / SPRO
Atlas Venture Associates Ix, LLC’s Spero Therapeutics Inc Position
Does Atlas Venture Associates Ix, LLC own Spero Therapeutics Inc (SPRO)? Yes — 1.35M shares worth $2M (+13.93% of its 13F portfolio) as of Q3 2023.
Position Value
$2M
Q3 2023
Shares
1.35M
% of Portfolio
+13.93%
Quarters Held
20
currently held
Position History SPRO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 1.35M | $2M | +13.93% |
| Q2 2023 | 1.35M | $2M | +10.74% |
| Q1 2023 | 1.38M | $2M | +9.37% |
| Q4 2022 | 1.38M | $2M | +11.85% |
| Q3 2022 | 1.38M | $3M | +8.16% |
| Q2 2022 | 1.38M | $1M | +2.32% |
| Q1 2022 | 1.38M | $12M | +11.02% |
| Q4 2021 | 1.38M | $22M | +9.62% |
| Q3 2021 | 1.38M | $25M | +8.43% |
| Q2 2021 | 1.38M | $19M | +3.38% |
| Q1 2021 | 1.38M | $20M | +3.41% |
| Q4 2020 | 1.38M | $27M | +4.23% |
| Q3 2020 | 1.38M | $15M | +15.90% |
| Q2 2020 | 1.38M | $19M | +19.92% |
| Q1 2020 | 1.38M | $11M | +23.53% |
| Q4 2019 | 1.38M | $13M | +23.08% |
| Q3 2019 | 1.38M | $15M | +24.02% |
| Q2 2019 | 1.38M | $16M | +16.95% |
| Q1 2019 | 1.38M | $18M | +16.57% |
| Q4 2018 | 1.38M | $8M | +9.75% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atlas Venture Associates Ix, LLC’s full portfolio or all institutional holders of SPRO.